Gregory Hale

Gregory Hale is a senior medical professional currently serving as Vice President at Medpace, a clinical research organization. Here are key details about his background and expertise:

Professional Experience

Dr. Hale joined Medpace in May 2017 as Senior Medical Director and has since been promoted to Vice President.13 He brings extensive experience in clinical development, particularly in translating novel therapies for patients with solid tumors and hematologic malignancies. His focus areas include:

• Immuno-oncology
• Molecularly targeted therapies
• Advanced cellular and gene therapies

Medical Background

Dr. Hale is a board-certified physician with specializations in:

• General Pediatrics
• Pediatric Hematology Oncology

He has over 20 years of experience in clinical medicine, translational research, and healthcare management.3 Some of his previous roles include:

• Professor of Oncology and Pediatrics at Johns Hopkins University
• Medical Director of Pediatric Hematology, Oncology, and BMT at Johns Hopkins All Children's Hospital
• Clinical Director of the Blood and Marrow Transplant Service at St. Jude Children's Research Hospital

Education and Qualifications

• M.D. from Marshall University Joan C. Edwards School of Medicine (1986-1990)
• B.S. in Chemistry from Marshall University (1986)
• MBA in Business Administration and Management from University of Massachusetts Amherst (2016-2019)

Dr. Hale also holds various healthcare certifications, including Certified Physician Executive and Certified Professional in Healthcare Quality.2

Expertise and Contributions

At Medpace, Dr. Hale contributes his expertise in:

• Clinical trial design and conduct
• Medical monitoring
• Bone marrow transplantation
• Cellular therapies
• Hematologic malignancies

His experience as a principal investigator in over 200 clinical trials enhances Medpace's capabilities in oncology and advanced therapies research.13